Hepion Pharmaceuticals Inc

-0.84 (-7.22%)
7:45:59 PM EDT: $10.60 -0.20 (-1.85%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Hepion Pharmaceuticals Inc Stock, NASDAQ:HEPA

399 Thornall Street, 1st Floor, Edison, New Jersey 08837
United States of America
Phone: +1.732.902.4000
Number of Employees: 25


Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.